Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

P-selectin glycoprotein ligand-1 deficiency augments G-CSF induced myeloid cell mobilization.

Miszti-Blasius K, Felszeghy S, Kiss C, Benkő I, Géresi K, Megyeri A, Hevessy Z, Kappelmayer J.

Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):109-18. doi: 10.1007/s00210-013-0913-9. Epub 2013 Oct 5.

PMID:
24091681
[PubMed - indexed for MEDLINE]
3.

A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.

To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.

Blood. 1994 Nov 1;84(9):2930-9.

PMID:
7524760
[PubMed - indexed for MEDLINE]
Free Article
4.

Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.

Alexander ET, Towery JA, Miller AN, Kramer C, Hogan KR, Squires JE, Stuart RK, Costa LJ.

Transfusion. 2011 Sep;51(9):1995-2000. doi: 10.1111/j.1537-2995.2011.03085.x. Epub 2011 Mar 10.

PMID:
21392017
[PubMed - indexed for MEDLINE]
6.

Respiratory burst of neutrophils is not required for stem cell mobilization in mice.

van Os R, Robinson SN, Drukteinis D, Sheridan TM, Mauch PM.

Br J Haematol. 2000 Nov;111(2):695-9.

PMID:
11122123
[PubMed - indexed for MEDLINE]
7.

[The response of bone marrow hematopoietic cells to G-CSF in paroxysmal nocturnal hemoglobinuria patients].

Cao YR, Shao ZH, Liu H, Shi J, Bai J, Tu MF, Wang HQ, Xing LM, Cui ZZ, Sun J, Jia HR, Yang TY.

Zhonghua Xue Ye Xue Za Zhi. 2005 Apr;26(4):235-8. Chinese.

PMID:
15949269
[PubMed - indexed for MEDLINE]
8.

Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice.

Sudo Y, Shimazaki C, Ashihara E, Kikuta T, Hirai H, Sumikuma T, Yamagata N, Goto H, Inaba T, Fujita N, Nakagawa M.

Blood. 1997 May 1;89(9):3186-91.

PMID:
9129021
[PubMed - indexed for MEDLINE]
Free Article
9.

Effect of stem cell mobilization with cyclophosphamide plus granulocyte colony-stimulating factor on morphology of haematopoietic organs in mice.

Szumilas P, Barcew K, Baśkiewicz-Masiuk M, Wiszniewska B, Ratajczak MZ, Machaliński B.

Cell Prolif. 2005 Feb;38(1):47-61.

PMID:
15679866
[PubMed - indexed for MEDLINE]
10.
11.

Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice.

Fazzi R, Testi R, Trasciatti S, Galimberti S, Rosini S, Piras F, L'Abbate G, Conte A, Petrini M.

Leuk Res. 2002 Jan;26(1):19-27.

PMID:
11734300
[PubMed - indexed for MEDLINE]
12.

Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor.

Roberts AW, Foote S, Alexander WS, Scott C, Robb L, Metcalf D.

Blood. 1997 Apr 15;89(8):2736-44.

PMID:
9108391
[PubMed - indexed for MEDLINE]
Free Article
13.

Rapid down modulation of P-selectin glycoprotein ligand-1 (PSGL-1, CD162) by G-CSF in humans.

Jilma B, Hergovich N, Homoncik M, Marsik C, Kreuzer C, Jilma-Stohlawetz P.

Transfusion. 2002 Mar;42(3):328-33.

PMID:
11961238
[PubMed - indexed for MEDLINE]
14.

Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells.

Lévesque JP, Hendy J, Winkler IG, Takamatsu Y, Simmons PJ.

Exp Hematol. 2003 Feb;31(2):109-17.

PMID:
12591275
[PubMed - indexed for MEDLINE]
15.

Randomized cross-over trial of progenitor-cell mobilization: high-dose cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor plus G-CSF.

Koç ON, Gerson SL, Cooper BW, Laughlin M, Meyerson H, Kutteh L, Fox RM, Szekely EM, Tainer N, Lazarus HM.

J Clin Oncol. 2000 May;18(9):1824-30.

PMID:
10784622
[PubMed - indexed for MEDLINE]
16.

Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment.

Lévesque JP, Hendy J, Takamatsu Y, Williams B, Winkler IG, Simmons PJ.

Exp Hematol. 2002 May;30(5):440-9.

PMID:
12031650
[PubMed - indexed for MEDLINE]
17.

Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents.

van Os R, Robinson S, Sheridan T, Mislow JM, Dawes D, Mauch PM.

Blood. 1998 Sep 15;92(6):1950-6.

PMID:
9731052
[PubMed - indexed for MEDLINE]
Free Article
18.

Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.

Janowska-Wieczorek A, Marquez LA, Nabholtz JM, Cabuhat ML, Montaño J, Chang H, Rozmus J, Russell JA, Edwards DR, Turner AR.

Blood. 1999 May 15;93(10):3379-90.

PMID:
10233890
[PubMed - indexed for MEDLINE]
Free Article
19.

Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.

Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.

Exp Hematol. 1995 Dec;23(14):1520-6.

PMID:
8542941
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk